한글목차

세계 반도체 바이오칩 시장의 미래는 의료, 생명과학, 제약, 농업 시장에서의 기회로 유망합니다. 세계 반도체 바이오칩 시장은 2025-2031년 연평균 복합 성장률(CAGR) 18.2%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 개인 맞춤형 의료 및 현장 진단에 대한 수요 증가, 유전체 및 단백질체학 분야에서의 바이오칩 채택 확대, 의료 인프라 및 R&D 투자 증가 등입니다.

• Lucintel에 따르면, 유형별로는 액티브 칩이 예측 기간 동안 높은 성장세를 보일 것으로 예상했습니다.
• 용도별로는 의료 분야가 가장 높은 성장이 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

반도체 바이오칩 시장의 전략적 성장 기회

반도체 바이오칩 시장에는 다양한 응용 분야에 걸쳐 몇 가지 전략적 성장 기회가 존재합니다. 이러한 기회들은 다양한 분야에 통합될 수 있는 첨단 바이오칩 기술에 대한 수요의 급격한 증가를 의미하며, 이는 다양한 분야에 통합될 수 있습니다.

• 의료 진단: 의료는 진단 및 개인 맞춤형 의료에서 반도체 바이오칩에 많은 성장 기회를 제공합니다. 첨단 바이오칩은 더 높은 정확도와 빠른 속도로 질병을 식별하고 효과적인 치료를 가능하게 하여 시장 성장에 기여합니다.
• 의약품 개발 및 연구: 바이오칩은 의약품 개발 및 연구에 점점 더 많이 사용되고 있습니다. 하이스루풋 스크리닝, 바이오마커 탐색, 약물유전체학을 위한 바이오칩 개발은 제약업계의 혁신을 촉진할 수 있는 기회를 제공합니다.
• 환경 모니터링: 바이오칩을 환경 모니터링에 활용하는 것에 대한 관심이 높아지고 있습니다. 이러한 바이오칩은 오염물질과 유해물질을 감지할 수 있으며, 환경 보호와 규제 준수에 중요한 데이터를 제공합니다.
• 농업용: 반도체 바이오칩은 농작물 모니터링, 해충 감지 등 농업용으로 개발되고 있습니다. 이러한 바이오칩은 농업의 생산성과 지속가능성을 향상시킬 수 있는 솔루션을 제공합니다.
• 소비자 건강 및 복지: 바이오칩 기술은 소비자 건강 및 웰빙, 특히 개인 건강 모니터링에 적용하기 위해 연구되고 있습니다. 이는 개인의 건강을 실시간으로 모니터링하고 관리할 수 있는 웨어러블 바이오칩을 개발할 수 있는 기회를 제공합니다.

이러한 전략적 성장 기회는 바이오칩의 다양한 응용 분야를 보여줍니다. 의료, 의약품 개발, 환경 모니터링, 농업, 소비자 건강 등 대상 최종 사용 분야의 특성은 시장이 제공하는 것을 최대한 활용하고 그 적용 범위를 확대할 수 있는 혁신을 가능하게 합니다.

반도체 바이오칩 시장 활성화 요인 및 과제

반도체 바이오칩 시장의 성장과 개척에 영향을 미치는 다양한 촉진요인과 과제가 있습니다. 이를 이해함으로써 시장 내에서의 적절한 탐색을 보장할 수 있습니다. 반도체 바이오칩 시장은 주로 기술, 경제 요인, 규제 문제 등과 관련된 많은 촉진요인 및 과제에 영향을 받습니다. 이러한 요인들은 시장 내 동향을 결정하고 전체 산업의 발전을 형성하는 데 중요한 역할을 합니다.

반도체 바이오칩 시장을 견인하는 요인은 다음과 같습니다.

1. 개인맞춤형 의료에 대한 수요 증가: 개인맞춤형 의료에 대한 수요 증가: 개인맞춤형 의료에 대한 수요가 증가함에 따라 바이오칩에 대한 수요가 증가하고 있습니다. 바이오칩은 정밀한 진단을 가능하게 하고, 치료도 개인화할 수 있기 때문에 이 분야의 기술 혁신과 투자가 활발해지고 있습니다.

2. 의료비 지출 증가: 전 세계 의료비 지출 증가는 첨단 진단 도구 및 조사 기술에 대한 수요를 증가시키고 있으며, 그 결과 의료 혁신에 대한 투자 증가로 반도체 바이오칩 시장의 성장을 가속하고 있습니다.

3. 다양화: 바이오칩의 용도는 더 이상 전통적인 진단에 국한되지 않습니다. 환경 모니터링과 농업에도 적용되고 있습니다. 용도의 다양화는 시장 확대의 원동력이 되어 시장에 새로운 성장의 길을 열어줄 것입니다.

4. 전략적 제휴 및 협력: 기술 기업, 연구 기관, 의료 제공업체간의 제휴는 바이오칩 기술을 강화하고 있습니다. 이러한 제휴는 새로운 제품 및 용도를 개발하고 시장 개척을 촉진합니다.

반도체 바이오칩 시장의 과제는 다음과 같습니다.

1. 규제적 장애물: 바이오칩에는 다양한 규제적 장애물이 존재하며, 매우 복잡하고 비용이 많이 들 수 있습니다. 변화하는 표준에 대응하고 필요한 인허가를 적시에 취득하는 것은 어렵습니다.

2. 높은 개발 비용: 하이엔드 바이오칩 기술 개발에는 연구개발과 제조에 막대한 투자가 필요합니다. 높은 개발비용은 신규 진출기업 시장 개척을 방해하고 궁극적으로 수익성에 영향을 미칩니다.

3. 데이터 보안과 프라이버시 문제: 바이오칩은 심각한 건강 관련 데이터를 다루기 때문에 데이터 보안과 프라이버시가 중요한 문제입니다. 데이터 보호와 프라이버시 규정 준수가 큰 과제입니다.

반도체 바이오칩 시장 성장 촉진요인 및 과제는 업계의 성장이 다양한 복잡성을 특징으로 하고 있음을 보여줍니다. 기술 발전, 개인 맞춤형 의료, 의료비 지출 증가는 시장 성장을 가속하는 반면, 규제 문제, 높은 개발 비용, 데이터 보안 분석 등 심각한 과제를 야기하는 요인도 있습니다. 이러한 모든 요인들이 최전선에 있는 만큼, 시장에서의 성공과 혁신이 지속 가능한지 확인하지 않을 수 없을 것으로 보입니다.

목차

제1장 주요 요약

제2장 세계의 반도체 바이오칩 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 반도체 바이오칩 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 반도체 바이오칩 시장 : 유형별
  • 액티브 칩
  • 패시브 칩
• 세계의 반도체 바이오칩 시장 : 용도별
  • 의료
  • 생명과학
  • 제약
  • 농업
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 반도체 바이오칩 시장 : 지역별
• 북미의 반도체 바이오칩 시장
• 유럽의 반도체 바이오칩 시장
• 아시아태평양의 반도체 바이오칩 시장
• 기타 지역의 반도체 바이오칩 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 반도체 바이오칩 시장 성장 기회 : 유형별
  • 세계의 반도체 바이오칩 시장 성장 기회 : 용도별
  • 세계의 반도체 바이오칩 시장 성장 기회 : 지역별
• 세계 반도체 바이오칩 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 반도체 바이오칩 시장 생산능력 확대
  • 세계 반도체 바이오칩 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Thermo Fisher Scientific
• Cellix
• GE Healthcare
• Randox
• Biodot
• PerkinElmer
• Roche

영문목차

The future of the global semiconductor biochip market looks promising with opportunities in the medical, life science, pharmaceutical, and agricultural markets. The global semiconductor biochip market is expected to grow with a CAGR of 18.2% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized medicine and point-of-care diagnostics, the growing adoption of biochips in genomics and proteomics, and rising investments in healthcare infrastructure and research and development.

• Lucintel forecasts that, within the type category, the active chip is expected to witness higher growth over the forecast period.
• Within the application category, medical is expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Semiconductor Biochip Market

The semiconductor biochip market is evolving, with a few critical trends result of constantly evolving technology and expanding sets of applications. The aforementioned are going to reshape the industrial structure and spur creativity.

• Integration with AI and Machine Learning: Semiconductor biochips are increasingly integrated with AI and machine learning technologies. This integration enhances data analysis, improves diagnostic accuracy, and supports the development of personalized medicine, driving innovation in the biochip sector.
• Advancements in Microarray Technology: Recent improvements in microarray technology are increasing the capabilities of semiconductor biochips. Enhanced microarrays offer higher resolution, increased multiplexing, and improved sensitivity, enabling more detailed and accurate biomolecular analysis.
• Growth in Point-of-Care Diagnostics: The demand for point-of-care diagnostics is rising, driving innovations in semiconductor biochips designed for rapid, on-site testing. These biochips offer quick results and ease of use, addressing the need for efficient diagnostic tools in various healthcare settings.
• Focus on Personalized Medicine: There is a growing emphasis on personalized medicine, with biochips being developed to analyze genetic information and tailor treatments to individual patients. This trend supports the advancement of customized therapies and precision diagnostics.
• Expansion into Emerging Markets: Semiconductor biochip manufacturers are expanding their reach into emerging markets. This growth is driven by increasing healthcare needs, rising research capabilities, and investments in biotechnology infrastructure in regions such as Asia and Latin America.

While these trends are aligned to make changes in the semiconductor biochip market, there is a greater integration of advanced technologies, and with it, an improved ability to diagnose conditions. More applications are being found. The current focus is on AI, microarray advances, point-of-care diagnostics, and personalized medicine, inspiring innovation and driving growth in the sector.

Recent Developments in the Semiconductor Biochip Market

Recent developments in the semiconductor biochip market reveal advances in technology, increased applications, and strategic investments. These key happenings will shape the future of the market.

• Innovation in Biochip Technologies: Companies are investing in research and development to improve biochip technologies, such as the sensitivity of sensors and data processing. These innovations further enhance the performance of biochips in diagnostics, research, and other applications.
• Manufacturing Capability Expansion: There is clear expansion of manufacturing capabilities to meet the growing demand for biochips. New facilities and enhanced production processes further ramp up output and promote the growth of the market segment.
• Deals and Partnerships: Strategic partnerships between technology companies, research institutions, and healthcare systems further advancements in biochip technologies. Such partnerships will hasten the process of finding new uses and integrating these with already-developed healthcare systems.
• Increased Data Integration: The integration of biochips with data analytic platforms increases their functionality for research and diagnostic purposes. Advanced data processing and integration capabilities enhance the precision and speed of analyses based on biochips.
• Regulatory improvements have progressed to meet the unique demands of this technology and provide updated guidelines for diagnostics and research using biochips appropriately.

Advancing technology, growing capacities, and strategic partnerships are driving this market towards developments in data integration and changing regulations, thereby shaping the growth and application areas of the semiconductor biochip market.

Strategic Growth Opportunities for Semiconductor Biochip Market

Several strategic growth opportunities exist in the semiconductor biochip market across various fields of application. These opportunities collectively signify a surge in the demand for advanced biochip technology with potential integrations into different fields.

• Healthcare Diagnosis: Healthcare presents numerous growth opportunities for semiconductor biochips in diagnosis and personalized medicine. Advanced biochips can identify diseases with higher levels of accuracy and speed to enable effective treatments, thereby contributing to market growth.
• Drug Development and Research: Biochips are increasingly used in drug development and research. Opportunities exist in developing biochips for high-throughput screening, biomarker discovery, and pharmacogenomics, driving innovation in the pharmaceutical industry.
• Environmental Monitoring: There is growing interest in using biochips for environmental monitoring. These biochips can detect pollutants and hazardous substances, providing valuable data for environmental protection and compliance.
• Agricultural Applications: Semiconductor biochips are being developed for agricultural applications, including crop monitoring and pest detection. These biochips offer solutions for improving agricultural productivity and sustainability.
• Consumer Health and Wellness: Biochip technologies are being studied for use in consumer health and wellness, especially personal health monitoring. This creates opportunities for the development of wearable biochips to monitor and manage individual health in real-time.

These strategic growth opportunities demonstrate different areas of application for biochips. The nature of targeted end-use sectors, such as healthcare, drug development, environmental monitoring, agriculture, and consumer health, allows innovation to enable the market to maximize its offerings and expand its outreach.

Semiconductor Biochip Market Driver and Challenges

There are various drivers and challenges that influence the growth and development of the semiconductor biochip market. Understanding these will help ensure proper navigation within the market. The semiconductor biochip market is influenced by a host of drivers and challenges, mainly relating to technology, economic factors, and regulatory issues, among others. These factors are important in determining the trends within the market, which shape the progress of the industry as a whole.

The factors responsible for driving the semiconductor biochip market include:

1. Growing Demand for Personalized Medicine: There is a growing demand for biochips along with the rising demand for personalized medicine. Biochips facilitate diagnostics with high levels of precision; thus, treatments can also be personalized, which is driving more innovation and investment in this area.

2. Increased Healthcare Spend: Increased healthcare spending worldwide is raising demand for advanced diagnostic tools and research technologies, which, in turn, helps the semiconductor biochip market grow by investing more in healthcare innovations.

3. Diversification: The applications of biochips are no longer confined to conventional diagnostics. It also finds applications in environmental monitoring and agriculture. The diversified applications drive market expansion and hence create newer avenues of growth for the market.

4. Strategic Partnerships and Collaborations: The collaborations between technology companies, research institutions, and healthcare providers are enhancing biochip technologies. Such partnerships develop new products and applications, thus fostering market growth.

Challenges in the semiconductor biochip market are:

1. Regulatory Hurdles: There are various regulatory hurdles regarding biochips, which can be very complex and expensive. It is difficult to comply with changing standards and to secure necessary approvals in a timely manner.

2. High Development Cost: The development of high-end biochip technologies requires huge investments in R&D and manufacturing. High development costs reduce market entry by any new player, ultimately affecting profitability.

3. Data Security and Privacy Issue: Biochips deal with serious health-related data; hence, data security and privacy are the prime issues. Addressing the concerns of data protection and compliance with privacy regulations is a major challenge.

The drivers and challenges to the semiconductor biochip market indicate that industry growth is characterized by various complexities. Technological advancement, personalized medicine, and rising healthcare expenditure drive the growth in the market, but on the other hand, some factors contribute towards significant challenges, including regulatory challenges, high development costs, and data security analysis. With all these factors at the forefront, it will be impossible not to make sure that success and innovation are sustainable in the market.

List of Semiconductor Biochip Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies semiconductor biochip companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the semiconductor biochip companies profiled in this report include-

• Thermo Fisher Scientific
• Cellix
• GE Healthcare
• Randox
• Biodot
• PerkinElmer
• Roche

Semiconductor Biochip by Segment

The study includes a forecast for the global semiconductor biochip market by type, application, and region.

Semiconductor Biochip Market by Type [Analysis by Value from 2019 to 2031]:

• Active Chips
• Passive Chips

Semiconductor Biochip Market by Application [Analysis by Value from 2019 to 2031]:

• Medical
• Life Science
• Pharmaceutical
• Agricultural
• Others

Semiconductor Biochip Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Semiconductor Biochip Market

The semiconductor biochip market is one of the fastest-evolving markets in modern times due to rapid advancements in technology, an increase in applications, and continuous changes in regulations. Recent developments across different major regions, such as the United States, China, Germany, India, and Japan, illuminate the global growth and transformation in the sector.

• United States: Due to high investment in research and development and healthcare-based application development, growth has been recorded in the US semiconductor biochip market. The emergence of precision medicine and personalized diagnostics increases demand for biochips with higher functionality and greater accuracy.
• China: China is investing significantly in the research development and manufacturing of semiconductor biochips to enhance its biotechnology industry. Emphasis is being placed on increasing manufacturing capacities and integrating biochips into various diagnostic and research applications.
• Germany: Germany represents a semiconductor biochip market where innovations and integrations are essential prerequisites in the existing German health system. Countries like Germany have tech firms and research institutions cooperating in the advancement of technology to make biochips applicable for medical diagnostics and drug development.
• India: India presents a fast-evolving semiconductor biochip market, with a wide array of healthcare infrastructure and research facilities. Recent developments include low-cost biochip solutions to meet local healthcare needs and the requirements of its emerging biotech sector.
• Japan: Japan is making state-of-the-art contributions to semiconductor biochip technologies for applications related to genomics and personalized medicine. Key recent developments include advances in microarray technologies and their integration with artificial intelligence, enhancing data analytics and diagnostics.

Features of the Global Semiconductor Biochip Market

Market Size Estimates: Semiconductor biochip market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Semiconductor biochip market size by type, application, and region in terms of value ($B).

Regional Analysis: Semiconductor biochip market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the semiconductor biochip market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the semiconductor biochip market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the semiconductor biochip market by type (active chips and passive chips), application (medical, life science, pharmaceutical, agricultural, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Semiconductor Biochip Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Semiconductor Biochip Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Semiconductor Biochip Market by Type
  • 3.3.1: Active Chips
  • 3.3.2: Passive Chips
• 3.4: Global Semiconductor Biochip Market by Application
  • 3.4.1: Medical
  • 3.4.2: Life Science
  • 3.4.3: Pharmaceutical
  • 3.4.4: Agricultural
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Semiconductor Biochip Market by Region
• 4.2: North American Semiconductor Biochip Market
  • 4.2.1: North American Market by Type: Active Chips and Passive Chips
  • 4.2.2: North American Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others
• 4.3: European Semiconductor Biochip Market
  • 4.3.1: European Market by Type: Active Chips and Passive Chips
  • 4.3.2: European Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others
• 4.4: APAC Semiconductor Biochip Market
  • 4.4.1: APAC Market by Type: Active Chips and Passive Chips
  • 4.4.2: APAC Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others
• 4.5: ROW Semiconductor Biochip Market
  • 4.5.1: ROW Market by Type: Active Chips and Passive Chips
  • 4.5.2: ROW Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Semiconductor Biochip Market by Type
  • 6.1.2: Growth Opportunities for the Global Semiconductor Biochip Market by Application
  • 6.1.3: Growth Opportunities for the Global Semiconductor Biochip Market by Region
• 6.2: Emerging Trends in the Global Semiconductor Biochip Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Semiconductor Biochip Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Semiconductor Biochip Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Cellix
• 7.3: GE Healthcare
• 7.4: Randox
• 7.5: Biodot
• 7.6: PerkinElmer
• 7.7: Roche